serw-MX  [xml]  
 


    
 DeCS Categories

C04 Neoplasms .
C04.588 Neoplasms by Site .
C04.588.945 Urogenital Neoplasms .
C04.588.945.440 Genital Neoplasms, Male .
C04.588.945.440.770 Prostatic Neoplasms .
C04.588.945.440.770.500 Prostatic Neoplasms, Castration-Resistant .
C12 Male Urogenital Diseases .
C12.294 Genital Diseases, Male .
C12.294.260 Genital Neoplasms, Male .
C12.294.260.750 Prostatic Neoplasms .
C12.294.260.750.500 Prostatic Neoplasms, Castration-Resistant .
C12.294.565 Prostatic Diseases .
C12.294.565.625 Prostatic Neoplasms .
C12.294.565.625.500 Prostatic Neoplasms, Castration-Resistant .
C12.758 Urogenital Neoplasms .
C12.758.409 Genital Neoplasms, Male .
C12.758.409.750 Prostatic Neoplasms .
C12.758.409.750.500 Prostatic Neoplasms, Castration-Resistant .
E01 Diagnosis .
E01.370 Diagnostic Techniques and Procedures .
E01.370.225 Clinical Laboratory Techniques .
E01.370.225.500 Cytological Techniques .
E01.370.225.500.363 Cell Separation .
E01.370.225.500.363.342 Flow Cytometry .
E01.370.225.500.386 Cytophotometry .
E01.370.225.500.386.350 Flow Cytometry .
E01.370.520 Monitoring, Physiologic .
E05 Investigative Techniques .
E05.196 Chemistry Techniques, Analytical .
E05.196.712 Photometry .
E05.196.712.516 Luminescent Measurements .
E05.196.712.516.600 Fluorometry .
E05.196.712.516.600.240 Cytophotometry .
E05.196.712.516.600.240.350 Flow Cytometry .
E05.200 Clinical Laboratory Techniques .
E05.200.500 Cytological Techniques .
E05.200.500.363 Cell Separation .
E05.200.500.363.342 Flow Cytometry .
E05.200.500.386 Cytophotometry .
E05.200.500.386.350 Flow Cytometry .
E05.242 Cytological Techniques .
E05.242.363 Cell Separation .
E05.242.363.342 Flow Cytometry .
E05.242.386 Cytophotometry .
E05.242.386.350 Flow Cytometry .
E05.318 Epidemiologic Methods .
E05.318.308 Data Collection .
E05.318.308.980 Surveys and Questionnaires .
E05.318.308.980.344 Health Care Surveys .
E05.318.308.980.344.500 Patient Reported Outcome Measures .
E05.318.308.980.438 Health Surveys .
E05.318.308.980.438.475 Health Status Indicators .
E05.978 Weights and Measures .
H01 Natural Science Disciplines .
H01.770 Science .
H01.770.644 Research .
H01.770.644.145 Biomedical Research .
H01.770.644.145.431 Outcome Assessment (Health Care) .
N03 Health Care Economics and Organizations .
N03.349 Health Planning .
N03.349.380 Health Services Research .
N03.349.380.210 Health Care Surveys .
N03.349.380.210.750 Patient Reported Outcome Measures .
N04 Health Services Administration .
N04.761 Quality of Health Care .
N04.761.559 Outcome and Process Assessment (Health Care) .
N04.761.559.590 Outcome Assessment (Health Care) .
N04.761.559.590.399 Patient Outcome Assessment .
N04.761.559.590.399.875 Patient Reported Outcome Measures .
N04.761.744 Quality Improvement .
N04.761.744.500 Meaningful Use .
N05 Health Care Quality, Access, and Evaluation .
N05.425 Health Services Research .
N05.425.210 Health Care Surveys .
N05.425.210.500 Patient Reported Outcome Measures .
N05.715 Quality of Health Care .
N05.715.360 Health Care Evaluation Mechanisms .
N05.715.360.300 Data Collection .
N05.715.360.300.800 Surveys and Questionnaires .
N05.715.360.300.800.344 Health Care Surveys .
N05.715.360.300.800.344.500 Patient Reported Outcome Measures .
N05.715.360.300.800.438 Health Surveys .
N05.715.360.300.800.438.375 Health Status Indicators .
N05.715.360.575 Outcome and Process Assessment (Health Care) .
N05.715.360.575.575 Outcome Assessment (Health Care) .
N05.715.360.575.575.399 Patient Outcome Assessment .
N05.715.360.575.575.399.875 Patient Reported Outcome Measures .
N06 Environment and Public Health .
N06.850 Public Health .
N06.850.520 Epidemiologic Methods .
N06.850.520.308 Data Collection .
N06.850.520.308.980 Surveys and Questionnaires .
N06.850.520.308.980.344 Health Care Surveys .
N06.850.520.308.980.344.500 Patient Reported Outcome Measures .
N06.850.520.308.980.438 Health Surveys .
N06.850.520.308.980.438.475 Health Status Indicators .
SH1 Health Sciences, Technology and Innovation Management .
SH1.030 Resources for Research .
SH1.030.050 Indicators (Statistics) .
SH1.030.050.030 Health Status Indicators .
SP3 Population Studies in Public Health .
SP3.071 Methodology .
SP3.071.167 Measurements, Methods and Theories .
SP3.071.167.143 Population Estimates .
SP4 Environmental Health .
SP4.011 Science .
SP4.011.127 Social Sciences .
SP4.011.127.413 Demography .
SP4.011.127.413.629 Statistics as Topic .
SP4.011.127.413.629.890 Health Status Indicators .
SP4.011.127.413.639 Health Status Indicators .
SP5 Epidemiology and Biostatistics .
SP5.006 Biostatistics .
SP5.006.067 Health Status Indicators .
SP8 Disasters .
SP8.473 Risk 17142 .
SP8.473.654 Hazards .
SP8.473.654.692 Techniques, Measures, Measurement Equipment .
SP8.473.654.692.787 Weights and Measures .
SP8.473.654.692.792 Techniques .
SP8.473.654.692.792.692 Weights and Measures .
 
 Terms
 Synonyms & Historicals
Documents
LILACS e MDL
 
Outcome Assessment (Health Care) .
Assessment, Outcomes .
Outcome Measures .
Outcome Studies .
Outcomes Assessment .
Assessment, Outcome (Health Care) .
Assessments, Outcome (Health Care) .
Assessments, Outcomes .
Measure, Outcome .
Measures, Outcome .
Outcome Assessments (Health Care) .
Outcome Measure .
Outcome Study .
Outcomes Assessments .
Research, Outcomes .
Studies, Outcome .
Study, Outcome .
Outcomes Research .
Health Outcomes .
Outcomes Assessment .
Outcome Assessment .
Research aimed at assessing the quality and effectiveness of health care as measured by the attainment of a specified end result or outcome. Measures include parameters such as improved health, lowered morbidity or mortality, and improvement of abnormal states (such as elevated blood pressure). .
1.00
60761143
 
Health Status Indicators .
Health Status Indexes .
Appraisal, Health Risk .
Appraisals, Health Risk .
Health Risk Appraisals .
Health Status Indicator .
Health Status Indices .
Index, Health Status .
Indexes, Health Status .
Indicator, Health Status .
Indicators, Health Status .
Indices, Health Status .
Risk Appraisal, Health .
Risk Appraisals, Health .
Health Risk Appraisal .
Basic Health Indicators .
Health Status Index .
Indicators of Health Status .
The measurement of the health status for a given population using a variety of indices, including morbidity, mortality, and available health resources. .
0.38
226622018
 
Population Estimates .
Measurements to determine the size and characteristics (such as fertility and mortality) of a population at some time in the past, present or future. .
0.37
900
 
Patient Reported Outcome Measures .
Patient Reported Outcome .
Patient Reported Outcomes .
Outcome, Patient Reported .
Outcomes, Patient Reported .
Reported Outcome, Patient .
Reported Outcomes, Patient .
Assessment of the quality and effectiveness of health care as measured and directly reported by the patient. .
0.37
8892
 
Flow Cytometry .
Cell Sorting, Fluorescence-Activated .
Cell Sortings, Fluorescence-Activated .
Cytofluorometries, Flow .
Cytometries, Flow .
Flow Cytofluorometries .
Flow Cytofluorometry .
Flow Cytometries .
Flow Microfluorometries .
Flow Microfluorometry .
Fluorescence Activated Cell Sorting .
Fluorescence-Activated Cell Sortings .
Microfluorimetry, Flow .
Microfluorometries, Flow .
Sorting, Fluorescence-Activated Cell .
Sortings, Fluorescence-Activated Cell .
Cytofluorometry, Flow .
Cytometry, Flow .
Microfluorometry, Flow .
Flow Microfluorimetry .
Fluorescence-Activated Cell Sorting .
Technique using an instrument system for making, processing, and displaying one or more measurements on individual cells obtained from a cell suspension. Cells are usually stained with one or more fluorescent dyes specific to cell components of interest, e.g., DNA, and fluorescence of each cell is measured as it rapidly transverses the excitation beam (laser or mercury arc lamp). Fluorescence provides a quantitative measure of various biochemical and biophysical properties of the cell, as well as a basis for cell sorting. Other measurable optical parameters include light absorption and light scattering, the latter being applicable to the measurement of cell size, shape, density, granularity, and stain uptake. .
0.35
739120214
 
Weights and Measures .
Measures .
Scales .
Weights .
Measure .
Measures and Weights .
Measuring and weighing systems and processes. .
0.34
4122357
 
Monitoring, Physiologic .
Monitoring, Physiological .
Physiologic Monitoring .
Monitoring, Patient .
Physiological Monitoring .
Patient Monitoring .
The continuous measurement of physiological processes, blood pressure, heart rate, renal output, reflexes, respiration, etc., in a patient or experimental animal; includes pharmacologic monitoring, the measurement of administered drugs or their metabolites in the blood, tissues, or urine. .
0.34
64949747
 
Prostatic Neoplasms, Castration-Resistant .
Androgen-Independent Prostatic Cancer .
Androgen-Independent Prostatic Neoplasms .
Androgen-Insensitive Prostatic Cancer .
Androgen-Insensitive Prostatic Neoplasms .
Androgen-Resistant Prostatic Cancer .
Androgen-Resistant Prostatic Neoplasms .
Castration-Resistant Prostatic Cancer .
Castration-Resistant Prostatic Neoplasms .
Hormone Refractory Prostatic Cancer .
Hormone Refractory Prostatic Neoplasms .
Prostatic Cancer, Androgen-Independent .
Prostatic Cancer, Androgen-Insensitive .
Prostatic Cancer, Androgen-Resistant .
Prostatic Cancer, Castration-Resistant .
Prostatic Cancer, Hormone Refractory .
Prostatic Neoplasms, Androgen-Independent .
Prostatic Neoplasms, Androgen-Insensitive .
Prostatic Neoplasms, Androgen-Resistant .
Prostatic Neoplasms, Hormone Refractory .
Androgen Independent Prostatic Cancer .
Androgen Independent Prostatic Neoplasms .
Androgen Insensitive Prostatic Cancer .
Androgen Insensitive Prostatic Neoplasms .
Androgen Resistant Prostatic Cancer .
Androgen Resistant Prostatic Neoplasms .
Androgen-Independent Prostatic Cancers .
Androgen-Independent Prostatic Neoplasm .
Androgen-Insensitive Prostatic Cancers .
Androgen-Insensitive Prostatic Neoplasm .
Androgen-Resistant Prostatic Cancers .
Androgen-Resistant Prostatic Neoplasm .
Cancer, Androgen-Independent Prostatic .
Cancer, Androgen-Insensitive Prostatic .
Cancer, Androgen-Resistant Prostatic .
Cancer, Castration-Resistant Prostatic .
Cancers, Androgen-Independent Prostatic .
Cancers, Androgen-Insensitive Prostatic .
Cancers, Androgen-Resistant Prostatic .
Cancers, Castration-Resistant Prostatic .
Castration Resistant Prostatic Cancer .
Castration Resistant Prostatic Neoplasms .
Castration-Resistant Prostatic Cancers .
Castration-Resistant Prostatic Neoplasm .
Neoplasm, Androgen-Independent Prostatic .
Neoplasm, Androgen-Insensitive Prostatic .
Neoplasm, Androgen-Resistant Prostatic .
Neoplasm, Castration-Resistant Prostatic .
Neoplasms, Androgen-Independent Prostatic .
Neoplasms, Androgen-Insensitive Prostatic .
Neoplasms, Androgen-Resistant Prostatic .
Neoplasms, Castration-Resistant Prostatic .
Prostatic Cancer, Androgen Independent .
Prostatic Cancer, Androgen Insensitive .
Prostatic Cancer, Androgen Resistant .
Prostatic Cancer, Castration Resistant .
Prostatic Cancers, Androgen-Independent .
Prostatic Cancers, Androgen-Insensitive .
Prostatic Cancers, Androgen-Resistant .
Prostatic Cancers, Castration-Resistant .
Prostatic Neoplasm, Androgen-Independent .
Prostatic Neoplasm, Androgen-Insensitive .
Prostatic Neoplasm, Androgen-Resistant .
Prostatic Neoplasm, Castration-Resistant .
Prostatic Neoplasms, Androgen Independent .
Prostatic Neoplasms, Androgen Insensitive .
Prostatic Neoplasms, Androgen Resistant .
Prostatic Neoplasms, Castration Resistant .
Tumors or cancer of the PROSTATE which can grow in the presence of low or residual amount of androgen hormones such as TESTOSTERONE. .
0.32
121988
 
Meaningful Use .
Meaningful Uses .
Use, Meaningful .
Uses, Meaningful .
Using certified ELECTRONIC HEALTH RECORDS technology to improve quality, safety, efficiency, and reduce HEALTHCARE DISPARITIES; engage patients and families in their health care; improve care coordination; improve population and public health; while maintaining privacy and security. .
0.32
2704